BioSpace News Archive

Business

Neos Therapeutics to Host Fourth Quarter and Year-End 2018 Financial and Operating Results Conference Call on March 14th, 2019

Neos Therapeutics, Inc. today announced that it will report its fourth quarter and year-end 2018 financial results prior to the opening of U.S. financial markets on Thursday, March 14, 2019.

March 8, 2019
·
1 min read
Potential New Treatment for Heart Attack

Prospective drug found by testing in human heart muscle grown from stem cells

March 8, 2019
·
8 min read
Policy

Eisai’s Marketing Authorization Application for Potential Insomnia Disorder Treatment Lemborexant Submitted in Japan

Eisai Co., Ltd. has announced that a marketing authorization application has been submitted in Japan for lemborexant, an investigational agent for sleep-wake regulation, seeking approval for use in the treatment of insomnia disorder.

March 8, 2019
·
11 min read
EVOTEC TO ATTEND UPCOMING INVESTOR CONFERENCES

Evotec AG announced that its management will be presenting at and attending the following upcoming conferences:

March 8, 2019
·
2 min read
Business

CRF Bracket Welcomes Susie Robinson as Chief People Officer

Strategic Senior Appointment Spearheads Compelling Work Culture for Continued Success

March 8, 2019
·
2 min read
MorphoSys Provides Updates on L-MIND and B-MIND Clinical Trials of MOR208 in Relapsed/Refractory DLBCL

MorphoSys AG provided updates on L-MIND and B-MIND, its two ongoing clinical trials of the investigational Fc- enhanced anti-CD19 antibody MOR208 in patients with relapsed or refractory diffuse large B cell lymphoma, who are not eligible for high-dose chemotherapy and autologous stem cell transplantation.

March 8, 2019
·
8 min read
BioCapital

SCRS Announces the Launch of New and Improved Website

The Society for Clinical Research Sites is pleased to announce the launch of our new website at MySCRS.org.

March 8, 2019
·
1 min read
Business

Martin Shkreli Uses a Contraband Cell Phone to Run His Old Company From Behind Bars

Martin Shkreli may be behind bars, but that doesn’t mean he does not take a direct hand in running Turing Pharmaceuticals, the company that has been redubbed Phoenixus AG. The WSJ reports that Shkreli is still very much involved in the leadership of the company he founded.

March 8, 2019
·
2 min read
·
Alex Keown
Drug Development

J&J and ViiV Healthcare’s 2-Drug Monthly HIV Shots Equal to Daily Pills

Often, patients prefer oral medications over receiving an injection or infusion, but daily pills sometimes result in compliance problems. In the case of this combination injection, it would, if approved, require patients to visit a clinic or physician once a month for the shot.

March 8, 2019
·
2 min read
·
Mark Terry
FDA

FDA Action Alert: Regeneron, Celgene and Aerie

The next couple of weeks look to be busy for the FDA, with a string of target action dates scheduled. This week marks three scheduled approvals, two for extra indications for already-approved biologics, and the third for a combination treatment for glaucoma. Here’s a look.

March 8, 2019
·
3 min read
·
Mark Terry